Pacific Biosciences
PACB
#7750
Rank
ยฃ0.31 B
Marketcap
ยฃ1.02
Share price
-2.86%
Change (1 day)
-10.89%
Change (1 year)

Pacific Biosciences (PACB) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : ยฃ0.58 Billion

According to Pacific Biosciences 's latest financial reports the company's total liabilities are ยฃ0.58 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Pacific Biosciences - Total liabilities on balance sheet (from 2009 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ0.57 B-3.74%
2024-12-31ยฃ0.60 B-26.74%
2023-12-31ยฃ0.82 B-17.62%
2022-12-31ยฃ0.99 B10.49%
2021-12-31ยฃ0.90 B1464.42%
2020-12-31ยฃ57.58 M-18.87%
2019-12-31ยฃ70.97 M60.26%
2018-12-31ยฃ44.28 M3.23%
2017-12-31ยฃ42.9 M-0.53%
2016-12-31ยฃ43.12 M11.02%
2015-12-31ยฃ38.84 M-12.9%
2014-12-31ยฃ44.6 M9.8%
2013-12-31ยฃ40.62 M223.41%
2012-12-31ยฃ12.56 M-27.3%
2011-12-31ยฃ17.27 M3.05%
2010-12-31ยฃ16.76 M-90.25%
2009-12-31ยฃ0.17 B22.03%
2008-12-31ยฃ0.14 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ45.95 B 7,748.73%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ82.43 B 13,977.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ2.91 B 397.82%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
ยฃ4.95 B 746.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
ยฃ0.24 B-58.30%๐Ÿ‡บ๐Ÿ‡ธ USA